health
worker
high
risk
infect
asymptomat
transmit
viru
fragil
cancer
patient
screen
health
worker
cancer
institut
rapid
serolog
test
vivadiag
associatediggigm
six
subject
result
vivadiag
test
notneg
igm
case
rtpcr
test
neg
repeat
analysi
ofiggigm
express
clia
assay
also
case
result
igm
posit
case
iggigm
posit
latter
subject
report
contact
infect
person
month
earlierin
conclus
studi
seem
suggest
differ
analyt
sensit
iniggigm
evalu
vivadiag
clia
assay
need
determin
b
abil
vivadiagrapid
test
evid
health
worker
posit
immunoglobulin
express
discord
result
rapid
serolog
test
respect
rtpcr
stress
differ
clinic
mean
two
assay
question
clearli
refer
studi
optim
util
rapid
serolog
test
asymptomat
subject
high
risk
infect
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
recent
novel
coronaviru
first
report
respons
interperson
transmiss
lethal
pneumonia
china
subsequ
caus
transmiss
diseas
identifi
new
strain
coronaviru
famili
name
associ
diseas
call
coronaviru
diseas
rapidli
spreadal
world
oblig
govern
take
extraordinari
initi
action
roll
tri
control
pandem
includ
establish
strict
criteria
defin
patient
oropharyng
swab
collect
molecular
diagnosi
rtpcr
test
identif
viral
nucleic
acid
current
standard
method
diagnosingthi
diseas
howev
despit
action
worldwid
case
climb
million
death
analysi
situat
expert
highlightedsever
e
e
c
e
c
n
b
e
u
r
c
e
f
n
f
e
c
n
r
n
n
n
h
e
r
p
n
w
h
c
h
r
e
c
l
r
e
l
e
r
e
g
r
h
e
n
e
e
e
n
f
h
g
h
r
k
c
e
g
r
e
h
b
e
e
x
p
e
n
f
e
c
n
h
h
e
b
e
p
r
e
c
e
n
h
e
h
b
e
p
c
p
e
n
l
c
r
r
e
r
f
v
r
u
c
u
n
g
u
n
e
x
p
e
c
e
r
n
n
p
r
f
r
e
l
e
r
l
n
v
u
l
n
h
e
w
h
c
r
b
e
h
e
c
e
g
r
g
r
e
e
r
r
k
f
c
v
n
f
e
c
n
b
v
u
l
r
e
p
r
e
e
n
e
b
h
e
l
h
c
r
e
w
r
k
e
r
n
e
l
l
r
e
c
e
n
l
r
e
p
r
e
h
n
l
f
h
e
l
h
w
r
k
e
r
c
u
l
b
e
n
f
e
c
e
move
need
identifyunknown
sourc
infect
adopt
better
rule
diagnosi
person
high
risk
ofinfect
attempt
alreadi
made
identifi
infect
peopl
nurs
facil
hospit
use
rtpcrto
test
posit
rtpcr
test
identif
viral
nucleic
acid
current
standard
method
diagnos
howev
assay
practic
limit
annoy
method
obtain
biolog
materi
nasopharynx
rel
long
time
gener
result
andth
need
certifi
laboratori
specif
expertis
saw
swee
hock
school
public
health
nation
univers
singapor
recent
review
diagnost
test
infect
current
undergo
clinic
valid
also
list
immunoassay
detect
relat
igg
andigm
antibodi
latter
experiment
attempt
base
previou
experi
epidem
viral
sar
infect
argu
specif
igm
antibodi
could
detect
blood
day
iggdetect
occur
day
later
approach
describ
easi
handl
capabl
provid
result
minut
base
theinform
alreadi
report
consid
need
screen
healthcar
personnel
whoar
constantli
front
line
work
immunodepress
cancer
patient
util
assay
could
appli
larg
cohort
asymptomaticsubject
purpos
plan
screen
health
worker
cancer
institut
associ
immunoglobulin
rapid
serolog
test
vivadiag
tm
furthermor
repeat
test
subject
vivadiag
tm
assayposit
forigg
andor
igm
standard
rtpcr
serolog
test
also
plan
aim
studi
verifi
abil
vivadiag
tm
kit
identifi
subject
posit
relatedimmunoglobulin
asymptomat
cohort
subject
b
gather
inform
percentag
healthwork
true
risk
viru
exposur
hospit
march
april
health
worker
employ
istitutotumori
g
paolo
ii
ircc
bari
invit
particip
prospect
trial
venou
blood
sampl
taken
allth
particip
asymptomat
health
workersand
submit
toarapid
serolog
test
vivadiag
tm
studi
approv
ethic
committe
istitutotumori
g
paolo
ii
ircc
bari
protocol
number
ce
togeth
inform
consent
form
explain
quantit
serum
immunoglobulin
test
would
perform
blood
sampl
standard
rtpcr
assay
carri
swab
sampl
caseswher
suspect
infect
flag
vivadiag
tm
test
total
worker
repli
enrolledaft
signingtheir
written
inform
consent
form
participantsfil
questionnair
collect
inform
possibl
risk
infect
contact
confirm
posit
individualsor
visit
area
circul
venou
blood
sampl
collect
andimmedi
sent
clinicalpathologylaboratori
certifi
head
e
savino
institut
biobank
certifi
head
paradiso
theistitutotumori
g
paolo
ii
ircc
bari
vivadiag
test
perform
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
characterist
health
worker
enter
studi
report
tabl
median
age
year
rang
yr
male
total
enrol
worker
involv
direct
clinic
activ
laboratori
practic
administr
activ
maintenanceclean
activ
report
minor
clinic
symptom
directli
refer
diseas
report
direct
contact
individu
suspect
diseas
last
two
week
rapid
iggigm
combin
antibodi
test
kit
vivadiag
tm
design
manufactur
jiangsu
medom
medic
technolog
nanjingchina
later
flow
qualit
immunoassay
rapid
determin
presenc
absenc
human
specimen
whole
blood
serum
plasma
surfac
antigen
specif
bind
antibodi
includ
igm
igg
conjug
colloid
gold
nanoparticl
spray
onto
conjug
pad
rapid
iggigm
combin
antibodi
test
strip
two
mous
antihuman
monoclon
antibodi
antiigg
antiigm
strip
two
separ
test
line
presenc
igg
igm
antibodi
indic
redpurpl
line
appear
specif
region
antibodieson
devic
specimen
contain
antibodi
label
complex
bound
test
evalu
two
oper
pictur
taken
result
case
disagr
two
oper
pictur
evalu
third
parti
case
suspect
base
vivadiag
tm
test
result
oropharyng
swab
collectedon
follow
day
standard
rtpcr
test
rtpcr
test
immedi
perform
andigm
clia
accord
manufactur
indic
shenzhen
new
industri
biomed
engin
co
ltd
wwwsnibecom
briefli
kit
design
forindirect
chemiluminesc
qualitativesemiquantit
vitro
immunoassayof
igg
igm
antibodi
human
plasma
serumth
predilut
biolog
sampl
buffer
magnet
microbead
coat
recombin
antigen
mix
incub
creat
immunocomplexesaft
magnet
field
exposur
repeat
wash
igg
igm
antibodi
label
abei
ad
chemiluminesc
starter
activ
lightreact
detectedbi
photomultipi
biolumi
tm
wwwsnibecom
result
express
asrel
light
unit
rlu
cutoff
valu
test
determin
mean
luminesc
valu
normal
sera
plu
fold
sd
result
consid
posit
signalcutoff
sc
ratio
descript
analysi
vivadiag
tm
test
result
respect
health
worker
characterist
shownin
tabl
vivadiag
tm
test
resultsar
compar
laboratori
assay
result
tabl
total
health
worker
nation
cancer
research
center
istitutotumorig
paolo
ii
inbari
itali
enrol
takepart
inth
studi
equal
distribut
among
variou
work
categori
particip
routin
daili
contact
clinic
depart
case
vivadiag
tm
test
tabl
provid
result
neg
weak
strong
stain
igm
band
one
case
test
describ
strong
iggigm
intensitythre
case
compris
latter
one
werehealth
workerswho
report
recent
contact
patient
none
present
clinic
symptom
associ
diseas
one
younger
year
age
day
vivadiag
tm
test
oropharyng
swab
collect
subject
rtpcr
test
none
test
result
posit
viru
tabl
order
gain
insight
theiggigmanalyt
sensit
provid
colorimetr
vivadiag
tm
kit
plasma
aliquot
vivadiag
test
blood
sampl
subject
util
clia
analysi
iggigm
clia
result
showedigm
posit
two
case
nurs
member
hospit
clean
staff
tabl
confirm
strong
posit
iggigm
third
one
asymptomat
infect
highlight
beon
major
sourc
spread
may
caus
escal
casesal
world
pioneer
effort
countri
screen
asymptomat
peopl
show
problem
easi
handl
small
town
voeuganeo
red
zone
quarantin
area
incid
casesin
northern
itali
inhabit
includ
asymptomat
individu
test
bystandard
rtpcr
attempt
carrier
six
asymptomat
individualswer
found
posit
iceland
biotech
compani
work
behalf
countryschief
epidemiologist
screen
gener
popul
preliminari
result
report
inhabitantstest
neg
result
findingsar
contrast
recent
figur
china
support
hypothesi
four
fifthsof
infect
subject
could
asymptomat
sum
truepreval
asymptomat
infect
person
matter
debat
definit
accept
repres
one
major
contributor
thespread
diseas
although
studi
provid
inform
specif
risk
categori
health
worker
categori
obvious
consid
categori
higher
risk
ofinfect
even
involv
gener
practic
specif
hospit
consequ
problem
detect
asymptomat
infect
health
worker
need
consid
one
primari
relevancepolici
enact
specificallyprotecthealthcar
worker
stymi
circul
viru
inth
sensitivecontext
work
order
gain
insight
aspect
epidem
asymptomat
worker
cancer
institut
immunodepress
patient
extrem
frequent
sporad
posit
case
recent
report
assay
util
rapid
serolog
colorimetr
test
believ
result
obtain
beof
great
interest
vivadiag
tm
test
abl
find
case
suspect
presenc
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
specificimmunoglobulin
figur
consid
line
percentag
asymptomat
posit
case
found
populationwid
experi
two
report
regard
healthcar
personnelar
fromth
netherland
andfrom
nursingcor
facil
washington
usa
netherland
reuskentest
health
workerswith
mild
respiratori
complaint
nine
hospit
found
positivekimbal
analyz
resid
longterm
care
skill
nurs
facil
report
test
posit
sinc
two
studi
involv
subject
facil
differ
characterist
respect
cancer
institut
present
experi
consid
first
address
problem
screen
asymptomat
health
worker
infect
studi
none
six
worker
test
posit
vivadiag
tm
kithad
oropharyng
swabsposit
upon
rtpcr
test
one
week
followup
six
operatorswer
still
asymptomat
find
subject
posit
covidspecif
igmigg
present
viral
load
agreement
lou
report
higher
ig
level
asynchron
respect
viral
presenc
persist
long
time
afterviru
rtpcr
testsbecom
negativeon
point
drew
attent
wasth
differ
vivadiag
tm
clia
detect
twoimmunoglobulin
snibe
wwwsnibecom
recent
announcedthat
maglumi
igmigg
kit
receivedit
ce
mark
consid
case
test
positivewith
thevivadiag
tm
kitand
neg
withth
cliamaglumikit
would
appearthatth
vivadiag
tm
testcould
greater
analyt
sensit
howev
studi
design
directli
compar
perform
two
assay
exclud
convers
better
specif
cliamaglumi
kit
neg
case
vivadiag
tm
kit
test
cliaassay
aspect
investig
ournext
trialin
case
doubl
vivadiag
clia
maglumi
kit
test
separ
discuss
deserv
case
strongli
posit
iggigm
serolog
test
subject
nurs
refer
contact
patient
easi
relat
herig
posit
event
first
time
screen
rapid
serolog
test
individu
singl
asymptomat
health
worker
presum
pass
viru
infect
within
cohort
hundr
subject
studi
seem
suggest
rapid
serolog
test
abil
individu
subject
previou
contact
viru
b
apercentag
albeit
small
asymptomat
health
worker
could
previous
expos
toth
viru
studi
requir
confirmand
fulli
interpret
find
propos
optim
util
serolog
test
clinic
b
l
e
c
h
r
c
e
r
c
f
h
e
c
h
r
f
w
r
k
e
r
c
r
e
e
n
e
f
r
c
v
e
e
b
r
p
e
r
l
g
c
l
e
v
v
right
reserv
reus
allow
without
permiss
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
peerreview
b
l
e
c
h
r
c
e
r
c
f
u
b
j
e
c
w
h
n
n
e
g
v
e
c
v
v
v
g
e
r
e
u
l
n
c
p
r
n
w
h
